Ignite Creation Date:
2025-12-25 @ 12:07 AM
Ignite Modification Date:
2026-01-03 @ 3:55 AM
Study NCT ID:
NCT04513158
Status:
TERMINATED
Last Update Posted:
2024-10-24
First Post:
2020-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection
Sponsor:
Joseph M. Flynn, D.O., MPH
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
20-N0124
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None